Literature DB >> 24240789

Clinical analysis of patients with pulmonary nontuberculous mycobacterial disease complicated by pneumothorax.

Yoshihiro Kobashi1, Keiji Mouri, Yasushi Obase, Shigeki Kato, Mikio Oka.   

Abstract

OBJECTIVE: We clarified the clinical characteristics of patients with pulmonary nontuberculous mycobacterial (NTM) disease complicated by pneumothorax.
METHODS: We retrospectively selected 220 patients who satisfied the diagnostic criteria for NTM disease proposed by the American Thoracic Society (ATS). Nine patients with pulmonary NTM disease were complicated with pneumothorax. We investigated the patients' background, laboratory findings, radiological findings, treatment and prognoses.
RESULTS: There were nine patients, including six men and three women, with a mean age of 73.2 years. Seven patients had underlying respiratory diseases such as chronic obstructive pulmonary disease (COPD) excluding pulmonary NTM disease. The causative microorganisms was Mycobacterium avium in four patients, M. intracellulare in four patients, and M. kansasii in one patient. Regarding the radiological findings, pneumothorax was recognized in the right lung in five patients, in the left lung in three patients, and in both lungs heterogeneously in one patient. Although most patients exhibited multiple cavities and extensive lesions over the unilateral lung fields, three patients were simultaneously diagnosed with pulmonary NTM disease at the onset of pneumothorax. As for treatment, thoracic drainage was performed in seven patients, while one patient was advised only to rest and one patient required both thoracic drainage and surgery. The responses to the treatment was poor in each case, and five patients died due to pneumonia or heart failure.
CONCLUSION: In this study, the rate of pneumothorax complications in the patients with pulmonary NTM disease (4.1%) was higher than that of other reports. The responses to treatment, and prognoses were poor due to the presence of other complications.

Entities:  

Mesh:

Year:  2013        PMID: 24240789     DOI: 10.2169/internalmedicine.52.0465

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

1.  Successful treatment of non-tuberculous mycobacterial pleurisy with acute fever by antimycobacterial therapy.

Authors:  Mako Yamoto; Yukio Kawagishi; Akari Murata; Hiroshi Tsuji
Journal:  BMJ Case Rep       Date:  2018-02-08

2.  The frequency and treatment of pneumothorax associated with pulmonary nontuberculous mycobacterial infection.

Authors:  Masaki Ikeda; Koji Takahashi; Teruya Komatsu; Toru Tanaka; Tatsuo Kato; Takuji Fujinaga
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-12-03

3.  Pulmonary Mycobacterium abscessus Subspecies abscessus Disease That Showed a Discrepancy Between the Genotype and Phenotype of Clarithromycin Resistance.

Authors:  Yusuke Yamaba; Osamu Takakuwa; Manami Saito; Daisuke Kawae; Misuzu Yoshihara; Yuta Mori; Eiji Kunii; Yutaka Ito; Shiomi Yoshida; Kenji Akita
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

4.  A Case of Pulmonary Mycobacterium kansasii Disease Complicated with Tension Pneumothorax.

Authors:  Ki Yung Boo; Jong Hoo Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-10-01

5.  Nontuberculous mycobacterial infection presenting as empyema and life threatening pneumothorax: A challenging situation in the emergency department.

Authors:  Shahzad Anjum; Ramsha Tahir; Sameer A Pathan
Journal:  Qatar Med J       Date:  2015-07-02

6.  Pneumothorax associated with nontuberculous mycobacteria: A retrospective study of 69 patients.

Authors:  Masako Ueyama; Takanori Asakura; Kozo Morimoto; Ho Namkoong; Shuichi Matsuda; Takeshi Osawa; Makoto Ishii; Naoki Hasegawa; Atsuyuki Kurashima; Hajime Goto
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 7.  Non-tuberculous mycobacterial lung disease: a brief review focusing on radiological findings.

Authors:  Laura Raniere Borges Dos Anjos; Poliana Lopes Parreira; Pedro Paulo Teixeira Silva Torres; André Kipnis; Ana Paula Junqueira-Kipnis; Marcelo Fouad Rabahi
Journal:  Rev Soc Bras Med Trop       Date:  2020-09-11       Impact factor: 1.581

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.